Inflammation is a well‐known driver of cancer progression in the primary niche since inflammatory responses mediated by inflammatory cytokines such as interleukins (ILs), tumor necrosis factor‐α (TNF‐α), and nuclear factor‐kappa B (NF‐κΒ), are involved in almost all stages of cancer as well as EMT.134, 135. Here, TNF is linked to cancer.